Orexigen Therapeutics Announces Proposed Public Offering of Common Stock and Warrants

Orexigen Therapeutics OREX announced that it intends to offer units in an underwritten public offering, with each unit consisting of one share of Orexigen's common stock and a warrant to purchase a certain number of shares of Orexigen's common stock. In connection with this offering, Orexigen expects to grant to the underwriter a 30-day option to purchase additional units to cover overallotments, if any. All of the units are being offered by Orexigen. Leerink Swann LLC is acting as sole book-running manager for the offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsOfferingsAfter-Hours Center
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!